Searched for
PRESCRIPTION FORMULATIONS
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- Govt ends over-the-counter sales of all 'syrups'; mandates doctor's prescription for purchaseThe Union Ministry of Health and Family Welfare has mandated that all syrups, including cough syrups, are now prescription-only. This new r...
- How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter?Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formul...
- Dr Reddy's launches oral semaglutide biosimilar Obeda in IndiaDr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
- Drug misuse: Govt may curb 'Pregabalin' salesThe government is looking to control the sale of Pregabalin. This common medicine is being misused. The government wants to make sure it is...
- Piramal Pharma to stay away from prescription business in India: Nandini PiramalPiramal Pharma is not planning to re-enter the domestic prescription formulations business, according to chairperson Nandini Piramal. Inste...
- Sun Pharma net profit jumps 15% to Rs 2,903 crore in Q3FY25Sun Pharma's Q3FY25 net profit rose 15% YoY to ₹2,903 crore, driven by strong domestic and global specialty sales. Revenue grew 10.5%, whil...
- Taller, stronger, sharper: Desi pharma is on a rollThe Avendus Capital report attributed the eye-catching growth of large Indian pharma brands to lifestyle diseases, prevalent quality issues...
- Drug regulator forms panel to evaluate OTC candidatesThe sub-committee, which includes various doctors from the country's top government hospitals, representatives from Indian Council of Medic...
- Govt mulls allowing sale of common medicines in general storesIndia's committee, under Atul Goel's leadership, is pioneering the development of guidelines for over-the-counter medicines to improve acce...
- Why NMC's mandate for stopping branded generic prescriptions was uncalled forBranded generics also add significant value to the healthcare ecosystem. They develop and circulate patient education materials. In-patient...
- Generics-only policy makes sense only when targeted at pharmacists, not doctorsThe generics-only prescription rule does not make sense when quality of drugs remains suspect. Many have pointed outthat the NMC clause wil...
- You may soon need prescription for nicotine gums and patchesAs per the existing provisions under Schedule K of Drugs Rules, 1945, nicotine gum and lozenges containing up to 2mg of nicotine are exempt...
- Sales of pharmacological sunscreens are surging. Here's whyAccording to the most recent data compiled by research firm IMS, prescription sunblock sales increased by over 55 percent in May over 2020.
Load More
